Improving Performance in Drivers With Mild Cognitive Impairment
- Conditions
- Mild Cognitive Impairment
- Interventions
- Behavioral: Brain Health WorkshopBehavioral: Goal Management TrainingBehavioral: Processing Speed Training
- Registration Number
- NCT01935219
- Lead Sponsor
- Baycrest
- Brief Summary
The objective of this study is to assess the effectiveness of an intervention to address both executive function and processing speed changes that contribute to poor driving performance in adults with Mild Cognitive Impairment (MCI).
Our hypotheses are that the study intervention will improve performance on a driving simulator and will improve (i) executive function, specifically attention and planning, (ii) useful field of view, (iii) mood, (iv) quality of life, and (v) reported motor vehicle crashes and driving infractions.
- Detailed Description
Executive function and processing speed are recognized critical correlates of driving performance and have been shown to decline in older adults and in persons with mild cognitive impairment. Members of our research team have shown that group executive function training such as Goal Management Training results in benefits for healthy older adults, including improved simulated daily activities. The ultimate purpose of our research is to develop interventions to help maintain older adults' mobility in order to assist their 'aging at home'. The planned study will assess the effectiveness of an intervention that includes Goal Management Training + processing speed training (using DriveSharp software), which is designed to address both executive function and processing speed changes that contribute to poor driving performance in people with diagnosed mild cognitive impairment. The investigators will measure the effectiveness of the intervention on driving performance, sustained attention, divided attention, executive function, depressive symptoms and quality of life.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
- mild cognitive impairment
- currently driving or voluntarily stopped driving within the past year
- fluent in English
- visual problems that cannot be corrected with standard lenses
- alcohol/substance abuse
- stroke with residual motor /sensory deficit
- traumatic brain injury
- seizure in the past two years
- Parkinson's disease
- Multiple sclerosis
- untreated sleep apnea
- history of motion sickness
- history of dizziness, vertigo
- active primary psychiatric disorder requiring treatment
- on a dose of cognitive enhancing medication for less than 3 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Brain Health Workshop + computer assignments Brain Health Workshop Group participates in Brain Health Workshop and is provided with computer assignments to match for time spent on the computer in the other arms. Goal Management Training + Processing Speed Training Goal Management Training Group receives both Goal Management Training and as well as Processing Speed Training using DriveSharp software. Goal Management Training + Processing Speed Training Processing Speed Training Group receives both Goal Management Training and as well as Processing Speed Training using DriveSharp software. Processing Speed Training + Brain Health Workshop Brain Health Workshop Group receives both Processing Speed Training (using DriveSharp) and participates in a Brain Health Workshop that is matched to Goal Management Training for session length and contact with trainer. Processing Speed Training + Brain Health Workshop Processing Speed Training Group receives both Processing Speed Training (using DriveSharp) and participates in a Brain Health Workshop that is matched to Goal Management Training for session length and contact with trainer.
- Primary Outcome Measures
Name Time Method Driving Performance 33-38 weeks Measurements obtained on a computer-based driving simulation
- Secondary Outcome Measures
Name Time Method Sustained Attention to Response Task (SART) 9-14 weeks, 33-38 weeks Sustained attention
D-KEFs Tower Test 9-14 weeks, 33-38 weeks Visuospatial planning
Useful Field of View Test (UFOV) 9-14 weeks, 33-38 weeks Visual field of view
Cognitive Failures Questionnaire 9-14 weeks, 33-38 weeks Absentmindedness, executive dysfunction in daily life
Quality of Life: AD (QOL-AD) 9-14 weeks, 33-38 weeks Quality of life with MCI and Alzheimer's disease
Dysexecutive Questionnaire 9-14 weeks, 33-38 weeks Absentmindedness, executive dysfunction in daily life
Geriatric Depression Scale (GDS-15 item) 9-14 weeks, 33-38 weeks Depressive symptoms
Trial Locations
- Locations (1)
Baycrest Health Sciences
🇨🇦Toronto, Ontario, Canada